Vermont § 4601 - Definitions As used in this chapter:

§ 4601. Definitions As used in this chapter:

• (1) “Biological product” means a virus, therapeutic serum, toxin, antitoxin, vaccine,
  blood, blood component or derivative, allergenic product, protein (except any chemically
  synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine
  (or any other trivalent organic arsenic compound), applicable to the prevention, treatment,
  or cure of a disease or condition in human beings. (2) “Brand name” means the registered trademark name given to a drug product by its manufacturer
  or distributor. (3) “Generic drug” means a drug listed by generic name and considered to be chemically
  and therapeutically equivalent to a drug listed by brand name, as both names are identified
  in the most recent edition of or supplement to the U.S. Food and Drug Administration’s
  Approved Drug Products with Therapeutic Equivalence Evaluations (the Orange Book). (4) “Generic name” means the official name of a drug product as established by the U.
  S. Adopted Names Council (USAN) or its successor, if applicable. (5) “Interchangeable biological product” means a biological product that the U.S. Food
  and Drug Administration has: (A) licensed and determined, pursuant to 42 U.S.C. § 262(k)(4), to be interchangeable with the reference product against which it was evaluated
  as may be reflected in the U.S. Food and Drug Administration’s Lists of Licensed Biological
  Products with Reference Product Exclusivity and Biosimilarity or Interchangeability
  Evaluations (the Purple Book); or (B) determined to be therapeutically equivalent as set forth in the latest edition of
  or supplement to the U.S. Food and Drug Administration’s Approved Drug Products with
  Therapeutic Equivalence Evaluations (the Orange Book). (6) “Pharmacist” means a natural person licensed by the State Board of Pharmacy to prepare,
  compound, dispense, and sell drugs, medicines, chemicals, and poisons. (7) “Prescriber” means any duly licensed physician, dentist, veterinarian, or other practitioner
  licensed to write prescriptions for the treatment or prevention of disease in man
  or animal. (8) “Proper name” means the nonproprietary name of a biological product. (9) “Reference product” means the single biological product licensed pursuant to 42 U.S.C. § 262